ID

27736

Beschreibung

Methotrexate, Glucarpidase, and Leucovorin in Treating Patients With Newly Diagnosed Primary Central Nervous System Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT00727831

Link

https://clinicaltrials.gov/show/NCT00727831

Stichworte

  1. 27.11.17 27.11.17 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

27. November 2017

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Chemotherapeutic Agent Toxicity NCT00727831

Eligibility Chemotherapeutic Agent Toxicity NCT00727831

Criteria
Beschreibung

Criteria

histologically confirmed newly diagnosed primary cns lymphoma (pcnsl)
Beschreibung

Primary central nervous system lymphoma

Datentyp

boolean

Alias
UMLS CUI [1]
C0280803
previously untreated disease
Beschreibung

Disease untreated

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C0332155
diffuse large b-cell lymphoma histology
Beschreibung

Diffuse Large B-Cell Lymphoma

Datentyp

boolean

Alias
UMLS CUI [1]
C0079744
must be clinically eligible to receive standard 3 g/m² methotrexate if outside trial
Beschreibung

Methotrexate Dose

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0025677
UMLS CUI [1,2]
C0178602
no clinically significant effusions or edema
Beschreibung

Effusion Absent | Edema Absent

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0013687
UMLS CUI [1,2]
C0332197
UMLS CUI [2,1]
C0013604
UMLS CUI [2,2]
C0332197
patient characteristics:
Beschreibung

Client Characteristics

Datentyp

boolean

Alias
UMLS CUI [1]
C0815172
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
ecog performance status 0-3
Beschreibung

ECOG performance status

Datentyp

boolean

Alias
UMLS CUI [1]
C1520224
neutrophils ≥ 1 x 10^9/l
Beschreibung

Neutrophil count

Datentyp

boolean

Alias
UMLS CUI [1]
C0200633
platelet count ≥ 100 x 10^9/l
Beschreibung

Platelet Count measurement

Datentyp

boolean

Alias
UMLS CUI [1]
C0032181
bilirubin < 1.5 times upper limit of normal
Beschreibung

Serum total bilirubin measurement

Datentyp

boolean

Alias
UMLS CUI [1]
C1278039
glomerular filtration rate (initially measured by edta/isotope method) ≥ 50 ml/min
Beschreibung

Glomerular Filtration Rate EDTA Method

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0017654
UMLS CUI [1,2]
C0013618
UMLS CUI [1,3]
C0025663
not pregnant or nursing
Beschreibung

Pregnancy Absent | Breast Feeding Absent

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0032961
UMLS CUI [1,2]
C0332197
UMLS CUI [2,1]
C0006147
UMLS CUI [2,2]
C0332197
negative pregnancy test
Beschreibung

Pregnancy test negative

Datentyp

boolean

Alias
UMLS CUI [1]
C0427780
fertile patients must use effective contraception during and for 6 months after completion of study therapy
Beschreibung

Fertility Contraceptive methods

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0015895
UMLS CUI [1,2]
C0700589
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
hiv positivity
Beschreibung

HIV Seropositivity

Datentyp

boolean

Alias
UMLS CUI [1]
C0019699
dementia or neurological dysfunction not considered to be due to the pcnsl
Beschreibung

Dementia | Neurological Dysfunction | Primary central nervous system lymphoma Uninvolved

Datentyp

boolean

Alias
UMLS CUI [1]
C0497327
UMLS CUI [2]
C1709219
UMLS CUI [3,1]
C0280803
UMLS CUI [3,2]
C0205429
other serious or uncontrolled medical conditions
Beschreibung

Medical condition Serious | Medical condition Uncontrolled

Datentyp

boolean

Alias
UMLS CUI [1,1]
C3843040
UMLS CUI [1,2]
C0205404
UMLS CUI [2,1]
C3843040
UMLS CUI [2,2]
C0205318
prior malignancy, except adequately treated nonmelanoma skin cancer or carcinoma in situ
Beschreibung

Cancer Other | Exception Skin carcinoma Treated | Exception Carcinoma in Situ Treated

Datentyp

boolean

Alias
UMLS CUI [1]
C1707251
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0699893
UMLS CUI [2,3]
C1522326
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0007099
UMLS CUI [3,3]
C1522326
prior concurrent therapy:
Beschreibung

Therapeutic procedure

Datentyp

boolean

Alias
UMLS CUI [1]
C0087111
no prior cytotoxic chemotherapy
Beschreibung

Cytotoxic Chemotherapy

Datentyp

boolean

Alias
UMLS CUI [1]
C0677881
no concurrent prophylactic antibiotics
Beschreibung

Prophylactic antibiotic

Datentyp

boolean

Alias
UMLS CUI [1]
C0362063
no concurrent co-trimoxazole
Beschreibung

co-trimoxazole

Datentyp

boolean

Alias
UMLS CUI [1]
C0041044

Ähnliche Modelle

Eligibility Chemotherapeutic Agent Toxicity NCT00727831

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
Primary central nervous system lymphoma
Item
histologically confirmed newly diagnosed primary cns lymphoma (pcnsl)
boolean
C0280803 (UMLS CUI [1])
Disease untreated
Item
previously untreated disease
boolean
C0012634 (UMLS CUI [1,1])
C0332155 (UMLS CUI [1,2])
Diffuse Large B-Cell Lymphoma
Item
diffuse large b-cell lymphoma histology
boolean
C0079744 (UMLS CUI [1])
Methotrexate Dose
Item
must be clinically eligible to receive standard 3 g/m² methotrexate if outside trial
boolean
C0025677 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
Effusion Absent | Edema Absent
Item
no clinically significant effusions or edema
boolean
C0013687 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0013604 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
Client Characteristics
Item
patient characteristics:
boolean
C0815172 (UMLS CUI [1])
Item Group
C1512693 (UMLS CUI)
ECOG performance status
Item
ecog performance status 0-3
boolean
C1520224 (UMLS CUI [1])
Neutrophil count
Item
neutrophils ≥ 1 x 10^9/l
boolean
C0200633 (UMLS CUI [1])
Platelet Count measurement
Item
platelet count ≥ 100 x 10^9/l
boolean
C0032181 (UMLS CUI [1])
Serum total bilirubin measurement
Item
bilirubin < 1.5 times upper limit of normal
boolean
C1278039 (UMLS CUI [1])
Glomerular Filtration Rate EDTA Method
Item
glomerular filtration rate (initially measured by edta/isotope method) ≥ 50 ml/min
boolean
C0017654 (UMLS CUI [1,1])
C0013618 (UMLS CUI [1,2])
C0025663 (UMLS CUI [1,3])
Pregnancy Absent | Breast Feeding Absent
Item
not pregnant or nursing
boolean
C0032961 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0006147 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
Pregnancy test negative
Item
negative pregnancy test
boolean
C0427780 (UMLS CUI [1])
Fertility Contraceptive methods
Item
fertile patients must use effective contraception during and for 6 months after completion of study therapy
boolean
C0015895 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
HIV Seropositivity
Item
hiv positivity
boolean
C0019699 (UMLS CUI [1])
Dementia | Neurological Dysfunction | Primary central nervous system lymphoma Uninvolved
Item
dementia or neurological dysfunction not considered to be due to the pcnsl
boolean
C0497327 (UMLS CUI [1])
C1709219 (UMLS CUI [2])
C0280803 (UMLS CUI [3,1])
C0205429 (UMLS CUI [3,2])
Medical condition Serious | Medical condition Uncontrolled
Item
other serious or uncontrolled medical conditions
boolean
C3843040 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C3843040 (UMLS CUI [2,1])
C0205318 (UMLS CUI [2,2])
Cancer Other | Exception Skin carcinoma Treated | Exception Carcinoma in Situ Treated
Item
prior malignancy, except adequately treated nonmelanoma skin cancer or carcinoma in situ
boolean
C1707251 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0699893 (UMLS CUI [2,2])
C1522326 (UMLS CUI [2,3])
C1705847 (UMLS CUI [3,1])
C0007099 (UMLS CUI [3,2])
C1522326 (UMLS CUI [3,3])
Therapeutic procedure
Item
prior concurrent therapy:
boolean
C0087111 (UMLS CUI [1])
Cytotoxic Chemotherapy
Item
no prior cytotoxic chemotherapy
boolean
C0677881 (UMLS CUI [1])
Prophylactic antibiotic
Item
no concurrent prophylactic antibiotics
boolean
C0362063 (UMLS CUI [1])
co-trimoxazole
Item
no concurrent co-trimoxazole
boolean
C0041044 (UMLS CUI [1])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video